Redeye states that while short-term revenue acceleration is dampened by the component shortage, this is an attractive entry point for investors looking more than six months ahead. Redeye lowers its Base Case but sees a good upside in the case.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Sivers Semiconductors - Entering Inflection Point

© Modular Finance, source Nordic Press Releases